Cargando…
MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is among the ten most frequent and deadly cancers, without effective therapies for most patients. More recently, drugs targeting deregulated growth factor signaling receptors have been developed, such as HGF-MET targeted therapy. We assessed MET and HGF gene...
Autores principales: | Abboud, H.S., Camuzi, D., Rapozo, D.C., Fernandes, P.V., Nicolau-Neto, P., Guaraldi, S., Simão, T.A., Ribeiro Pinto, L.F., Gonzaga, I.M., Soares-Lima, S.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148886/ https://www.ncbi.nlm.nih.gov/pubmed/34037097 http://dx.doi.org/10.1590/1414-431X2020e10877 |
Ejemplares similares
-
The potential of mRNA expression evaluation in predicting HER2 positivity in gastroesophageal cancer
por: de Oliveira, I.M., et al.
Publicado: (2022) -
IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma
por: Soares-Lima, Sheila Coelho, et al.
Publicado: (2021) -
FBXL7 Body Hypomethylation Is Frequent in Tumors from the Digestive and Respiratory Tracts and Is Associated with Risk-Factor Exposure
por: Camuzi, Diego, et al.
Publicado: (2022) -
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays
por: Garcia, S, et al.
Publicado: (2007) -
Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis
por: Camuzi, Diego, et al.
Publicado: (2021)